Skip to Content
MilliporeSigma
All Photos(1)

Documents

BP383

Cytarabine

British Pharmacopoeia (BP) Reference Standard

Synonym(s):

Cytosine β-D-arabinofuranoside, (β-D-Arabinofuranosyl)cytosine, Ara-C, Arabinocytidine, Arabinosylcytosine, Cytarabine, Cytosine arabinoside

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C9H13N3O5
CAS Number:
147-94-4
Molecular Weight:
243.22
Beilstein/REAXYS Number:
89175
MDL number:
MFCD00066487
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

cytarabine

form

crystalline

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O

InChI

1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1

InChI key

UHDGCWIWMRVCDJ-CCXZUQQUSA-N

Gene Information

human ... POLA1(5422) , POLA2(23649) , POLD1(5424) , POLD2(5425) , POLD3(10714) , POLD4(57804) , POLE(5426) , POLE2(5427) , POLE3(54107) , PRIM1(5557) , PRIM2(5558)

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Cytarabine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Cytarabine Injection

    • Biochem/physiol Actions

    Ara-C incorporates into DNA and inhibits DNA replication by forming cleavage complexes with topoisomerase I resulting in DNA fragmentation; does not inhibit RNA synthesis. Anti-leukemia agent.

    Packaging

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    Other Notes

    Sales restrictions may apply.

    pictograms

    Health hazardExclamation mark
    GHS08,GHS07

    signalword

    Warning

    Hazard Classifications

    Repr. 2 - Skin Sens. 1

    wgk_germany

    WGK 3

    flash_point_f

    Not applicable

    flash_point_c

    Not applicable

    Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact Customer Support.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Customers Also Viewed

    Slide 1 of 7

    1 of 7

    Mitoxantrone dihydrochloride ≥97% (HPLC)

    Sigma-Aldrich

    M6545

    Mitoxantrone dihydrochloride

    Gemcitabine hydrochloride ≥98% (HPLC)

    Sigma-Aldrich

    G6423

    Gemcitabine hydrochloride

    5-Aza-2′-deoxycytidine ≥97%

    Sigma-Aldrich

    A3656

    5-Aza-2′-deoxycytidine

    Acetonitrile anhydrous, 99.8%

    Sigma-Aldrich

    271004

    Acetonitrile

    Mitomycin C from Streptomyces caespitosus powder, BioReagent, suitable for cell culture

    Sigma-Aldrich

    M4287

    Mitomycin C from Streptomyces caespitosus

    Dexamethasone powder, BioReagent, suitable for cell culture, ≥97%

    Sigma-Aldrich

    D4902

    Dexamethasone

    Retinoic acid ≥98% (HPLC), powder

    Sigma-Aldrich

    R2625

    Retinoic acid

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service